Curcumin: The multi-targeted therapy for cancer regression

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 1, 2012, Pages 335-355

  Md Sakib Hossain, Dewan ^a   Bhattacharyya, Sankar ^a   Das, Tanya ^a   Sa, Gaurisankar ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Angiogenesis; Apoptosis; Carcinogenesis; Chemoprevention; Curcumin; Metastasis; Review

Indexed keywords

ANTIOXIDANT; BETA CATENIN; CURCUMIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; PROTEIN BAX; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE C; PROTEIN P53; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ANTINEOPLASTIC AGENT; REACTIVE OXYGEN METABOLITE;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CONTROL; CANCER INHIBITION; CANCER REGRESSION; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHRONIC INFLAMMATION; CURCUMA LONGA; CYTOTOXIC T LYMPHOCYTE; DIET SUPPLEMENTATION; DNA DAMAGE; DRUG BIOAVAILABILITY; DRUG SAFETY; DRUG STRUCTURE; DRUG TRANSFORMATION; ENZYME INHIBITION; G2 PHASE CELL CYCLE CHECKPOINT; METASTASIS INHIBITION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CELL TRANSFORMATION; DRUG EFFECT; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; CURCUMIN; HUMANS; NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 84864122287     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (165)

1. A Tekiner, O Yucel, AK Sargin, O Genc, B Can, T Karayilanoglu, J Karakaya, MA Bayar: The effect of nitrogen mustard on the rat brain and the therapeutic value of proanthocyanidin. Turk Neurosurg 19, 360-366 (2009)
2. R Miller, HL McLeod: Pharmacogenomics of cancer chemotherapy-induced toxicity. J Support Oncol 5, 9-14 (2007)
3. M Pàez-Ribes, E Allen, J Hudock, T Takeda, H Okuyama, F Viñals, M Inoue, G Bergers, D Hanahan, O Casanovas: Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220-231 (2009)
4. T Das, G Sa, E Paszkiewicz-Kozik, C Hilston, L Molto, P Rayman, K Biswas, RM Bukowski, JH Finke, CS Tannenbaum: Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptorindependent pathways. J. Immunol 180, 4687-4696 (2008)
5. G Sa, T Das, C Moon, CM Hilston, PA Rayman, BI Rini, CS Tannenbaum, JH Finke: GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells. Cancer Res 69, 3095-3104 (2009)
6. T Das, G Sa, C Hilston, D Kudo, P Rayman, K Biswas, L Molto, R Bukowski, B Rini, J H. Finke, C Tannenbaum: GM1 and TNFa, overexpressed in renal cell carcinoma, synergize to induce T cell apoptosis. Cancer Res 68, 2014-2023 (2008)
7. L Zitvogel, L Apetoh, F Ghiringhelli, G Kroemer: Immunological aspects of cancer chemotherapy. Nat Rev Immunol 8, 59-73 (2008)
8. GK Jayaprakasha, L Jagan Mohan Rao, KK Sakariah: Chemistry and biological activities of C. longa. Trends in Food Science & Technology 16, 533-548 (2005)
9. World Health Organization. WHO monographs on selected medicinal plants: 1, 115-124 (1999)
10. F Kiuchi, Y Goto, N Sugimoto, N Akao, K Kondo, Y Tsuda: Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem Pharm Bull 41, 1640-1643 (1993)
11. GK Jayaprakasha, L Jagan Mohan Rao, KK Sakariah: Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. J Agric Food Chem 50, 3668-3672 (2002)
12. HH Tonnesen, J Karlsen, GB van Henegouwen: Studies on curcumin and curcuminoids. VIII. Photochemical stability of curcumin. Z Lebensm Unters Forsch 183, 116-122 (1986)
13. National Cancer Institute, DCPC. Clinical development plan: curcumin. J Cell Biochem 26, 72-85 (1996)
14. D Eigner, D Scholz: Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. J Ethnopharmacol 67, 1-6 (1999)
15. N Chainani-Wu: Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa) J Altern Complement Med 9, 161-168 (2003)
16. RA Sharma, CR Ireson, RD Verschoyle, KA Hill, ML Williams, C Leuratti, MM Manson, LJ Marnett, WP Steward, A. Gescher: Effects of dietary curcumin on glutathione Stransferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels. Clin Cancer Res 7, 1452-1458 (2001)
17. SD Deodhar, R Sethi, RC Srimal: Preliminary study on antirheumatic activity of curcumin (diferuloyl methane) Indian J. Med. Res 71, 632-634 (1980)
18. AL Cheng, CH Hsu and JK Lin: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21, 2895-2900 (2001)
19. RA Sharma, SA Euden, SL Platton: Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10, 6847-6854 (2004)
20. S Strimpakos, RA Sharma: Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10, 511-545 (2008)
21. C Ireson, S Orr, D. J. Jones: Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 61, 1058-64 (2001)
22. P Anand, AB Kunnumakkara, RA Newman, BB Aggarwal: Bioavailability of curcumin: problems and promises. Mol Pharm 4, 807-818 (2007)
23. G Shoba, D Joy, T Joseph, M Majeed, R Rajendran, PS Srinivas: Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64, 353-356 (1998)
24. L Li, FS Braiteh, R Kurzrock: Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104, 1322-1331 (2005)
25. C Karikar, A Maitra, S Bisht, G Feldmann, S Soni, R Ravi: Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J. Nanobiotechnol 5, 3 (2007)
26. A Liu, H Lou, L Zhao, P Fan: Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J. Pharm. Biomed. Anal 40, 720-727 (2006)
27. H Ohori, H Yamakoshi, M Tomizawa, M Shibuya, Y Kakudo, A Takahashi, S Takahashi, S Kato, T Suzuki, C Ishioka, Y Iwabuchi, H Shibata: Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Mol. Cancer Ther 5, 2563-2571 (2006)
28. SS Han, ST Chung, DA Robertson, D Ranjan, S Bondada: Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NFkappa B, and p53. Clin. Immuno.l 93, 152-61 (1999)
29. SP Verma, BR Goldin, PS Lin: The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids. Environ Health Perspect. 106, 807-812 (1998)
30. JG Brody, KB Moysich, O Humblet, KR Attfield, GP Beehler, RA Rudel: Environmental pollutants and breast cancer: epidemiologic studies. Cancer109, 2667-2711 (2007)
31. S Nishiumi, K Yoshida, H Ashida: Curcumin suppresses the transformation of an aryl hydrocarbon receptor through its phosphorylation. Arch Biochem Biophys. 466, 267-273 (2007)
32. H Choi, YS Chun, SW Kim, MS Kim, JW Park: Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol Pharmacol. 70, 1664-1671 (2006)
33. SP Verma, E Salamone B Goldin: Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides. Biochem Biophys Res Commun 233, 692-696 (1997)
34. N Li, X Chen, J Liao, G Yang, S Wang, Y Josephson, C Han, J Chen, MT Huang, CS Yang. Inhibition of 7,12- dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23, 1307-13 (2002)
35. MT Huang, W Ma, YP Lu, RL Chang, C Fischer, PS Manchand, HL Newmark, AH Conney: Effect of curcumin, demethoxycurcumin, bisdemethoxy-curcumin and tetrahydrocurcumin on TPA-induced tumor promotion. Carcinogenesis 16, 2493-2497 (1995)
36. MT Huang, RC Smart, CQ Wong, AH Conney: Inhibitory effect of curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12- O-tetradecanoylphorbol-13-acetate. Cancer Res 48, 5941- 5946 (1988)
37. MT Huang, ZY Wang, CA Georgiadis, JD Laskin, AH Conney: Inhibitory effect of curcumin on tumor initiation by benzo[a] pyrene and 7,12-dimethyl-benz[a] anthracene. Carcinogenesis 13, 947-954 (1992)
38. MT Huang, YR Lou, W Ma, HL Newmark, KR Reuhl, AH Conney: Inhibitory effects of dietary curcumin on forestomach, duodenal and colon carcinogenesis in mice. Cancer Res 54, 5841-5847 (1994)
39. CV Rao, A Riven, B Simi, BS Reddy: Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55, 259-266 (1995)
40. JW Pollard: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4, 71- 78 (2004)
41. H Ohsima: Curcumin, an anti-tumor promoter and antiinflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 206, 533-540 (1995)
42. MNA. Rao: Oxygen radical scavenging activity of curcumin. Int J Pharm 38, 239-240 (1990)
43. M Subramanian, MNA Sreejayan Rao, TPA Devasagyam, BB Singh: Diminution of singlet oxygeninduced DNA-damage by curcumin and related antioxidants. Mutat Res 311, 249-255 (1994)
44. RJ Verma: Curcumin ameliorates aflatoxin-induced lipid peroxidation in liver, kidney and testis of mice-an in vitro study. Acta Pol Pharm 64, 413-416 (2007)
45. MK Unnikrishnan, MN Rao: Curcumin inhibits nitrogen dioxide induced oxidation of hemoglobin. Mol Cell Biochem 146, 35-37 (1995)
46. M Iqbal, Y Okazaki, S Okada: Curcumin attenuates oxidative damage in animals treated with a renal carcinogen, ferric nitrilotriacetate (Fe-NTA): implications for cancer prevention. Mol Cell Biochem 324,157-64 (2009)
47. SM Plummer, KA Holloway, MM Manson: Inhibition of cyclooxygenase 2 expression in colon cells by chemopreventive agent curcumin involves inhibition of NF-?B activation via the NIK/IKK signaling complex. Oncogene 18, 6013-6020 (1999)
48. MSD Iqbal, Y Sharma, M Okazaki, S Okada: Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 92, 33-38 (2003)
49. Y Okazaki, M Iqbal, S Okada: Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate. Biochim Biophys Acta 1740, 357-366 (2005)
50. CK Andreadi, LM Howells, PA Atherfold, MM Manson: Involvement of Nrf2, p38, B-Raf, and nuclear factor-{kappa}B, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol Pharmacol 69, 1033-1040 (2006)
51. PF Firozi, VS Aboobaker, RK Bhattacharya: Action of curcumin on the cytochrome P450-system catalyzing the activation of aflatoxin B1. Chem Biol Interact 100, 41-51 (1996)
52. VS Yadav, KP Mishra, DP Singh, S Mehrotra, VK Singh: Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol 27, 485-497 (2005)
53. A Grandjean-Laquerriere, SC Gangloff, R Le Naour, C Trentesaux, W Hornebeck, M Guenounou: Relative contribution of NF-kappaB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVBinduced cytokine expression by keratinocytes. Cytokine 18, 168-177 (2002)
54. SS Han, YS Keum, HJ Seo, Y.J. Surh: Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 35, 337-342 (2002)
55. C Jobin, CA Bradham, MP Russo, B Juma, AS Narula, DA Brenner, RB Sartor: Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. Journal of Immunology 163, 3474-3483 (1999)
56. Y Bierhaus, P Zhang, T Quehenberger, M Luther, M Haase, M Muller, N Mackman, R Ziegler, PP Nawroth: The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thrombosis and Haemostasis 77, 772-782 (1997)
57. S Park, DK Lee, CH Yang: Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells. Cancer Letters 127 23-28 (1998)
58. T Kawamori, R Lubet, VE Steele, GJ Kelloff, RB Kaskey, CV Rao, BS Reddy: Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 59, 597-601 (1999)
59. RA Sharma, PB Farmer: Biological relevance of adduct detection to the chemoprevention of cancer. Clin Cancer Res 10, 4901-12 (2004)
60. S Perkins, RD Verschoyle, KA Hill: Chemopreventive efficacy and pharmacokinetics of curcumin in the Min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidem Biomar Prevent 11, 535-540 (2002)
61. NN Mahmoud, AM Carothers, D Grunberger: Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21, 921-927 (2000)
62. HS Samaha, GJ Kelloff, V Steele: Modulation of apoptosis by sulindac, curcumin, phenylethyl-3- methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 57, 1301- 1305 (1997)
63. T Dorai, N Gehani, A Katz: Therapeutic potential of curcumin in human prostate cancer - I. Prostate Cancer Dis 3, 84-93 (2000)
64. AP Chen, J Xu: Activation of PPAR gamma by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am J Physiol 288, G447- G456 (2005)
65. ML Kuo, TS Huang, JK Lin: Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta 1317, 95-100 (1996)
66. K Ozaki, Y Kawata, S Amano: Stimulatory effect of curcumin on osteoclast apoptosis, Biochem Pharmacol 59, 1577-1581 (2000)
67. Chen ZS Zhang, YL Zhang, DY Zhou: Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 19, 3675-3680 (1999)
68. CC Su, JG Lin, TM Li, JG Chung, JS Yang, SW Ip, WC Lin, GW Chen: Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3. Anticancer Res 26, 4379-89 (2006)
69. A Simon, DP Allais, JL Duroux, JP Basly, S Durand-Fontanier, C Delage: Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Lett 129, 111- 116 (1998)
70. MC Jiang, HF Yang Yen, JJY Yen: Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26, 111-120 (1996)
71. SC Gautam, YX Yong, KR Pndolia: Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane) Biochem Pharmacol 55, 1333-1337 (1998)
72. S Plummer, D Wakelin, M Bouer: Inhibition of growth of colon tumour cells by curcumin correlates with inhibition of the IkB kinase and down regulation of cyclin D1. Br J Cancer 83, 20 (2000)
73. SS Han, ST Chung, DA Robertson: Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol 93, 152-161 (1999)
74. S Bhaumik, MD Jyothi, A Khar: Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett 483, 78-82 (2000)
75. CH Yan, MS Jamaluddin, B Aggarwal: Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol Cancer Ther 4, 233-241 (2005)
76. AC Bharti, N Donato, S Singh, BB Aggarwal: Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053-62 (2003)
77. SS Han, YS Keum, HJ Seo, YJ Surh: Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 35, 337-42 (2002)
78. M Austinat, R Dunsch, C Wittekind, A Tannapfel, R Gebhardt, F Gaunitz: Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol Cancer 7, 21 (2008)
79. AS Jaiswal, BP Marlow, N Gupta, S Narayan: Betacatenin- mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)- induced growth arrest and apoptosis in colon cancer cells. Oncogene 21, 8414-8427 (2002)
80. CH Park, ER Hahm, S Park, HK Kim, CH Yang: The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling.FEBS Lett 579, 2965-2971 (2005)
81. A Chen, J Xu: Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am J Physiol Gastrointest Liver Physiol 288, G447-G456 (2005)
82. AR Hussain, M Al-Rasheed, PS Manogaran, KA Al- Hussein, LC Platanias, Al KK and S Uddin: Curcumin induces apoptosis via inhibition of PI3'-kinase/AKT pathway in acute T cell leukemias. Apoptosis 11, 245-54 (2006)
83. JH Woo, YH Kim, YJ Choi: Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, downregulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24, 1199-208 (2003)
84. JY Liu, SJ Lin, JK Lin: Inhibitory effects of curcumin on protein kinase C activity induced by12-Otetradecanoyl- phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 14, 857-61 (1993)
85. E Liu, J Wu, W Cao, J Zhang, W Liu, X Jiang, X Zhang: Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. J Neurooncol 85, 263-270 (2007)
86. JL Watson, A Greenshields, R Hill, A Hilchie, PW Lee, CA Giacomantonio, DW Hoskin: Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Mol Carcinog 49, 13-24 (2010)
87. T Choudhuri, S Pal, T Das, G Sa: Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280, 20059-20068 (2005)
88. NM Weir, K Selvendiran, VK Kutala, L Tong, S Vishwanath, M Rajaram, S Tridandapani, S Anant, P Kuppusamy: Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther 6, 178-184 (2007)
89. MC Jiang, HF. Yang-Yen, JJ Yen, JK Lin: Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26, 111-20 (1996)
90. C Martin-Cordero, M. Lopez-Lazaro, M Galvez, MJ Ayuso: Curcumin as a DNA topoisomerase II poison. J Enzyme Inhib Med Chem 18, 505-509 (2003)
91. G Mosieniak, M Sliwinska, K Piwocka, E Sikora: Curcumin abolishes apoptosis resistance of calcitrioldifferentiated HL-60 cells. FEBS Letters 580, 4653-60 (2006)
92. H Ligeret, S Barthelemy, R Zini, JP Tillement, S Labidalle, D Morin: Effects of curcumin and curcumin derivatives on mitochondrial permeability ransition pore. Free Radic Biol Med 36, 919-29 (2004)
93. AS Coutts, CJ Adams, NB La Thangue: p53 ubiquitination by Mdm2: a never ending tail? DNA Repair (Amst) 8, 483-90 (2009)
94. D Bech-Otschir, R Kraft, X Huang, P Henklein, B Kapelari, C Pollmann, W Dubiel: COP9 signalosomespecific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 20,1630-9(2001)
95. SH Jee, SC Shen, CR Tseng, HC Chiu, M.L. Kuo: Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol 111, 656-661 (1998)
96. T Choudhuri, S Pal, ML Agwarwal, T Das, G Sa: Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512, 334-340 (2002)
97. PJ Moos, K Edes, JE Mullally, FA Fitzpatrick: Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 25, 1611-1617 (2004)
98. G Song, YB Mao, QF Cai, LM Yao, GL Ouyang, SD Bao: Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Braz J Med Biol Res 38, 1791-1798 (2005)
99. MJ Park, EH Kim, IC Park, HC Lee, SH Woo, JY Lee, YJ Hong, CH Rhee, SH Choi, BS Shim, SH Lee, SI Hong: Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by upregulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53. Int J Oncol 21, 379- 383 (2002)
100. M Shi, Q Cai, L Yao, Y Mao, Y Ming, G Ouyang: Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int 30, 221-226 (2006)
101. JA Bush, KJ Jr Cheung, G Li: Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271, 305-314 (2001)
102. JE Mullally, FA Fitzpatrick: Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death. Mol Pharmacol 69, 351-358 (2002)
103. TC Hour, J Chen, CY Huang, JY Guan, SH Lu, YS Pu: Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation. Prostate 51, 211-218 (2002)
104. AC Bharti, N Donato, S Singh, BB Aggarwal: Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053-1062 (2003)
105. GP Collett, FC Campbell: Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 25, 2183- 2189 (2004)
106. NR Jana, P Dikshit, A Goswami, N Nukina: Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem 279, 11680-11685 (2004)
107. LS Cucuzza, M Motta, S Miretti, P Accornero, M Baratta: Curcuminoid-phospholipid complex induces apoptosis in mammary epithelial cells by STAT-3 signaling. Exp Mol Med 40, 647-657 (2008)
108. M Saydmohammed, D Joseph, V Syed: Curcumin suppresses constitutive activation of STAT-3 by upregulating protein inhibitor of activated STAT-3 (PIAS- 3) in ovarian and endometrial cancer cells. J Cell Biochem (2010)[Epub ahead of print].
109. F Thayyullathil, S Chathoth, A Hago, M Patel, S Galadari: Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and - independent apoptosis in L929 cells. Free Radic Biol Med 45, 1403-1412 (2008)
110. W Pan, H Yang, C Cao, X Song, B Wallin, R Kivlin, S Lu, G Hu, W Di, Y Wan: AMPK mediates curcumininduced cell death in CaOV3 ovarian cancer cells. Oncol Rep 20, 1553-1559 (2008)
111. AE Gururaj, M Belakavadi, DA Venkatesh, D Marmé, BP Salimath: Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 297, 934-942 (2002)
112. JL Arbiser, N Klauber, R Rohan, R van Leeuwen, MT Huang, C Fisher, E Flynn, HR Byers: Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 4, 376-383 (1998)
113. D Thaloor, AK Singh, GS Sidhu, PV Prasad, HK Kleinman, RK Maheshwari: Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 9, 305-312 (1998)
114. R Mohan, J Sivak, P Ashton, LA Russo, BQ Pham, N Kasahara, MB Raizman, ME Fini: Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor- 2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 275, 10405-10412 (2000)
115. ER Hahm, Y.S. Gho, S Park, C Park, KW Kim, CH Yang: Synthetic curcumin analogs inhibit activator protein- 1 transcription and tumor-induced angiogenesis. Biochem Biophys Res Commun 321, 337-344 (2004)
116. MK Bae, SH Kim, JW Jeong, YM Lee, HS Kim, SR Kim, I Yun, SK Bae, KW Kim: Curcumin inhibits hypoxiainduced angiogenesis via down-regulation of HIF-1. Oncol Rep 15, 1557-1562 (2006)
117. W Bao, K Li, S Rong, P Yao, L Hao, C Ying, X Zhang, A Nussler, L Liu: Curcumin alleviates ethanolinduced hepatocytes oxidative damage involving heme oxygenase-1 induction. J Ethnopharmacol 128, 549-553 (2010)
118. YG Lin, AB Kunnumakkara, A Nair, WM Merritt, LY Han, GN Armaiz-Pena, AA Kamat, WA Spannuth, DM Gershenson, SK Lutgendorf, BB Aggarwal, AK Sood: Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res 13, 3423-3430 (2007)
119. DE Sullivan, M Ferris, H Nguyen, E Abboud, AR Brody: TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation. J Cell Mol Med 13, 1866-1876 (2009)
120. HW Chen, JY Lee, JY Huang, CC Wang, WJ Chen, SF Su, CW Huang, CC Ho, JJ Chen, MF Tsai, SL Yu, PC Yang: Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 68, 7428-7438 (2008)
121. R Olszanecki, A Gebska, R Korbut: The role of haem oxygenase-1 in the decrease of endothelial intercellular adhesion molecule-1 expression by curcumin. Basic Clin Pharmacol Toxicol 101, 411-415 (2007)
122. S Yodkeeree, C Ampasavate, B Sung, BB Aggarwal, P. Limtrakul: Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. Eur J Pharmacol 627, 8-15 (2010)
123. B Bachmeier, AG Nerlich, CM Iancu, M Cilli, E Schleicher, R Vené, R Dell'Eva, M Jochum, A Albini, U Pfeffer: The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 19, 137-152 (2007)
124. SE Chuang, ML Kuo, CH Hsu, CR Chen, JK Lin, GM Lai, CY Hsieh, AL Cheng: Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 21, 331-335 (2000)
125. KW Lee, JH Kim, HJ Lee, YJ Surh: Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid Redox Signal 7, 1612-1620 (2005)
126. S Philip, GC Kundu: Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem 278, 14487-14497(2003)
127. JA Joyce, JW Pollard: Microenvironmental regulation of metastasis. Nat Rev Cancer 9, 239-252 (2009)
128. CH Park, ER Hahm, S Park, HK Kim, CH Yang: The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling. FEBS Lett 579, 2965-2971 (2005)
129. C Jae-We, L Kyu-Suk, K. Chang-Wook: Curcumin attenuates the expression of IL-1, IL-6, and TNF-a as well as cyclin e in TNF-a-treated hacat cells; NF-?B and MAPKs as potential upstream targets. Int J Mol Med 19, 469-474 (2007)
130. CW Lee, WN Lin, CC Lin: Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NFkappaB, p300, and histone acetylation. J Cell Physio 207, 174- 186 (2006)
131. MS Woo, SH Jung, SY Kim: Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem Biophys Res Commun 335, 1017- 1025 (2005)
132. BB Aggarwal, S Shishodia, Y Takada: Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11, 7490-7498 (2005)
133. S Chattopadhyay, S Bhattacharyya, B Saha, J Chakraborty , S Mohanty, DMSakib Hossain, S Banerjee, K Das, G Sa, T Das: Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins. PLoS One 4,e7382. (2009)
134. S Pal, S Bhattacharya, T Choudhuri, GK Datta, T Das, G Sa: Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor bearing mice by curcumin. Cancer Detection Prevention 29, 470-478 (2005)
135. G Sa, T Das: Anti cancer effects of curcumin: cycle of life and death. Cell Div 3, 14 (2008)
136. S Bhattacharyya, D Mandal, GS Sen, S Pal, S Banerjee, L Lahiry, JH Finke, CS Tannenbaum, T Das, G Sa: Tumorinduced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated Tcell death: protection by curcumin. Cancer Res 67, 362-70 (2007)
137. S Bhattacharyya, D Mandal, B Saha, GS Sen, T Das, G Sa: Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction. J Biol Chem 282, 15954-64 (2007)
138. S Bhattacharyya, M Hossain, S Mohanty, GS Sen, S Chattopadhyay, S Banerjee, J Chakraborty, K Das, D Sarkar, T Das, G Sa: Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cell Mol Immunol 2010 [Epub ahead of print].
139. HG Zhang, H Kim, C Liu, S Yu, J Wang, WE Grizzle, RP Kimberly, S Barnes: Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim Biophys Acta 1773, 1116-23 (2007)
140. S Toda, T Miyase, H Arichi, H Tanizawa, Y Takino: Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L. Chemical and Pharmaceutical Bulletin 33, 1725-1728 (1985)
141. A Barik, B Mishra, L. Shen: Evaluation of a new copper(II)-curcumin complex as superoxide dismutase mimic and its free radical reactions. Free Radic Biol Med 39, 811-22 (2005)
142. AC Reddy, BR Lokesh: Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Molecular and Cellular Biochemistry 137, 1-8 (1994)
143. MK Unnikrishnan, MN Rao: Curcumin inhibits nitrogen dioxide induced oxidation of hemoglobin. Molecular and Cellular Biochemistry 146, 35-37 (1995)
144. MNS Rao: Nitric oxide scavenging by curcuminoids. Journal of Pharmacy and Pharmacology 49, 105-107 (1997)
145. M Graziewicz, DA Wink, F Laval: Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage. Carcinogenesis 17, 2501-5 (1996)
146. AC Reddy, BR Lokesh: Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Molecular and Cellular Biochemistry 111, 117-124 (1992)
147. MNS. Rao: Curcuminoids as potent inhibitors of lipid peroxidation. Journal of Pharmacy and Pharmacology 46, 1013-1016 (1994)
148. HH Cohly, A Taylor, MF Angel, AK Salahudeen: Effect of turmeric, turmerin and curcumin on H2O2- induced renal epithelial (LLCPK1) cell injury. Free Radical Biology and Medicine 24, 49-54 (1998)
149. M Dikshit, L Rastogi, R Shukla, RC Srimal: Prevention of ischaemia-induced biochemical changes by curcumin and quinidine in the cat heart. Indian Journal of Medical Research 101, 31-35 (1995)
150. R Motterlini, R Foresti, R Bassi, CJ Green: Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radical Biology and Medicine 28, 1303-1312 (2000)
151. C Nirmala, R Puvanakrishnan: Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats. Biochemical Pharmacology 51, 47-51 (1996)
152. P Manikandan, M Sumitra, S Aishwarya, BM Manohar, B Lokanadam, R Puvanakrishnan: Curcumin modulates free radical quenching in myocardial ischaemia in rats. International Journal of Biochemistry and Cell Biology 36, 1967-1980 (2004)
153. C Nirmala, S Anand, R Puvanakrishnan: Curcumin treatment modulates collagen metabolism in isoproterenol induced myocardial necrosis in rats. Molecular and Cellular Biochemistry 197, 31-37 (1999)
154. EA Jones, A Shahed, DA Shoskes: Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology 56, 346-351 (2000)
155. MM Chan, HI Huang, MR Fenton, D. Fong: In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with antiinflammatory properties. Biochem Pharmacol 55, 1955-62 (1998)
156. CR Ireson, DJ Jones, S Orr: Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11, 105-11 (2002)
157. AT Dinkova-Kostova, P Talalay: Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcinogenesis 20, 911-14 (1999)
158. J Nair, S Strand, N Frank, J Knauft, H Wesch, PR Galle, H.Bartsch: Apoptosis and age-dependant induction of nuclear and mitochondrial etheno-DNA adducts in Long-Evans Cinnamon (LEC) rats: enhanced DNA damage by dietary curcumin upon copper accumulation. Carcinogenesis 26, 1307-15 (2005)
159. PK Lala, C Chakraborty: Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2, 149- 56 (2001)
160. G Garcea, DP Berry, DJ Jones: Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol. Biomarkers
161. HP Ciolino, PJ Daschner, TT Wang, GC Yeh: Effect of curcumin on the aryl hydrocarbon and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem Pharmacol 56, 197-206 (1998)
162. AT Dinkova-Kostova, P Talalay: Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcinogenesis 20, 911-14 (1999)
163. A Duvoix, M Schnekenburger, S Delhalle: Expression of glutathione S-transferase P1-1 in leukemic cells is regulated by inducible AP-1 binding. Cancer Lett 216, 207-19 (2004)
164. R Hayeshi, I Mutingwende, W Mavengere, V Masiyanise, S Mukanganyama: The inhibition of human glutathione S-transferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem Toxicol 45, 286-95 (2007)
165. tJD Hayes, DJ Pulford: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30, 445-600 (1995)